Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Besylsartan vs Amosartan in Healthy Males
NCT02504606Phase 1Completed
- Sponsor
- Huons
- Start
- Sep 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of amlodipine + losartan in hypertension (HTN) (2 arms), sponsored by Huons. Primary endpoints: Change from baseline in blood concentration of Amlodipine at 144 hours and Change from baseline in blood concentration of Losartan at 10 hours. Started Sep 2014; status: completed.
02
Drugs
amlodipine + losartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02504606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02504606.